A convenient, specific, precise, and reproducible radioimmunoassay system for measurement of triiodothyronine (T3) in human serum has been developed. The procedure compares the ability of standards and unknowns to compete with radioactive T3 for binding sites on a T3-binding antiserum produced in rabbits by immunization with human thyroglobulin. The assay is set up in the presence of 250 ng thyroxine (T4) in all tubes, to mobilize T3 from its binding with the thyronine-binding globulin (TBG), and athyreotic sheep serum in standards to correct for the TBG in the unknowns. The method regularly detected 0.4 ng T3, which would correspond to a T3 concentration of 100 ng/100 ml when 400 μl of serum is analyzed. The mean recovery of unlabeled T3 added to normal serum pools was 106%. Serial dilution of hyperthyroid sera containing high concentrations of T3 with athyreotic sheep serum yielded expected values.
Inder J. Chopra, David H. Solomon, Gildon N. Beall
Usage data is cumulative from December 2021 through December 2022.
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.